Investigation of Lipid Biomarkers in Amyotrophic Lateral Sclerosis Using Mass Spectrometry Imaging

Irma Berrueta Razo, Ping Yip, Andrey Gagunashvili, Andrea Malaspina, Laura Ajram and Philippa Hart

ELRIG Poster Investigation of Lipid Biomarkers in Amyotrophic Lateral Sclerosis Using Mass Spectrometry Imaging

Investigation of Lipid Biomarkers in Amyotrophic Lateral Sclerosis Using Mass Spectrometry Imaging

The application of Mass Spectrometry Imaging (MSI) can be used for the investigation of lipid metabolism dysregulation. Preclinical mouse brain and spinal cord tissues were analysed prior to human tissue from patients with slow and fast ALS progression to assess the link between altered metabolism of lipids and the progression of ALS.Investigation of Lipid Biomarkers in Amyotrophic Lateral Sclerosis Using Mass Spectrometry Imaging

This poster was created for ELRIG Drug Discovery 2022.

 

ELRIG Poster Investigation of Lipid Biomarkers in Amyotrophic Lateral Sclerosis Using Mass Spectrometry Imaging